Tongling Jieya Biologic Technology Co., Ltd. (SHE:301108)
China flag China · Delayed Price · Currency is CNY
27.27
0.00 (0.00%)
At close: May 6, 2026

SHE:301108 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
831.39762.82539.42592.39648.31970.23
Other Revenue
9.199.198.0330.218.2514.22
840.58772.01547.45622.59666.56984.45
Revenue Growth (YoY)
55.24%41.02%-12.07%-6.60%-32.29%32.50%
Cost of Revenue
629.83584.88448.21442.27461.97667.87
Gross Profit
210.75187.1399.24180.32204.59316.58
Selling, General & Admin
75.2865.1851.4655.6838.9129.1
Research & Development
29.8928.1920.4822.5225.2936.38
Other Operating Expenses
-1.151.080.560.724.867.13
Operating Expenses
113.91104.3480.6277.6969.8473.28
Operating Income
96.8482.7918.63102.63134.75243.31
Interest Expense
-1.39-1.39-0.77-1.01-1.86-1.62
Interest & Investment Income
18.8218.9615.1730.3824.66.05
Currency Exchange Gain (Loss)
-7.52-7.522.511.226.2-6.89
Other Non Operating Income (Expenses)
-14.13-3.510.78-0.23-0.16-0.24
EBT Excluding Unusual Items
92.6289.3236.32133163.52240.61
Gain (Loss) on Sale of Investments
5.375.355.59.061.011.2
Gain (Loss) on Sale of Assets
0.20.36-0.030.321.150.29
Asset Writedown
-13.38-10.55-17.49-10.51-11.46-0.42
Other Unusual Items
2.12.10.853.137.9510.18
Pretax Income
86.8986.5825.15135.01162.16251.85
Income Tax Expense
9.279.185.9720.4621.231.81
Earnings From Continuing Operations
77.6277.419.17114.54140.97220.05
Minority Interest in Earnings
-0.15-0.130.290.66--
Net Income
77.4877.2719.46115.2140.97220.05
Net Income to Common
77.4877.2719.46115.2140.97220.05
Net Income Growth
395.82%296.97%-83.10%-18.28%-35.94%22.50%
Shares Outstanding (Basic)
12311411411411388
Shares Outstanding (Diluted)
12311411411411388
Shares Change (YoY)
16.71%-0.76%0.81%0.14%29.59%2.66%
EPS (Basic)
0.630.680.171.011.242.51
EPS (Diluted)
0.630.680.171.011.242.51
EPS Growth
324.83%300.00%-83.24%-18.39%-50.57%19.32%
Free Cash Flow
-203.31-268.78-21.11-1.54269.1127.59
Free Cash Flow Per Share
-1.66-2.37-0.18-0.012.371.46
Dividend Per Share
0.2500.2500.1000.2570.3570.536
Dividend Growth
150.00%150.00%-61.10%-28.00%-33.34%-
Gross Margin
25.07%24.24%18.13%28.96%30.69%32.16%
Operating Margin
11.52%10.72%3.40%16.48%20.21%24.71%
Profit Margin
9.22%10.01%3.56%18.50%21.15%22.35%
Free Cash Flow Margin
-24.19%-34.82%-3.86%-0.25%40.37%12.96%
EBITDA
137.38124.0662.83134.32169.16271.94
EBITDA Margin
16.34%16.07%11.48%21.57%25.38%27.62%
D&A For EBITDA
40.5441.2844.231.6934.4128.63
EBIT
96.8482.7918.63102.63134.75243.31
EBIT Margin
11.52%10.72%3.40%16.48%20.21%24.71%
Effective Tax Rate
10.67%10.60%23.75%15.16%13.07%12.63%
Revenue as Reported
772.01772.01547.45622.59666.56984.45
Advertising Expenses
-0.080.060.40.180.05
Source: S&P Global Market Intelligence. Standard template. Financial Sources.